Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2025 14:58 ET | Source: PolTREG S.A.

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial FDA agreed that PolTREG’s clinical data in Stage 3...
July 04, 2025 06:15 ET | Source: PolTREG S.A.

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr....
June 13, 2025 11:47 ET | Source: PolTREG S.A.

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its...
March 06, 2024 06:55 ET | Source: ANTION BIOSCIENCES SA

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

Antion Biosciences release in vivo proof-of-concept data for miCAR7 and milestone achievement for Allogene Therapeutics
September 06, 2023 09:23 ET | Source: ANTION BIOSCIENCES SA

Antion Announces Granting of Key Technology Patent in the United States

GENEVA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is pleased to announce the granting of a significant patent...
August 09, 2023 06:55 ET | Source: ANTION BIOSCIENCES SA

Antion Welcomes John Tchelingerian as Chairman of the Board

GENEVA, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion) proudly announces the appointment of John Tchelingerian, PhD, a veteran of the biotech industry, as the new Chairman of its...